Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Pharmaceutical Excipients Market Evolve in Terms of Growth and Size by 2029?

The size of the pharmaceutical excipients market has witnessed substantial growth in the previous years. The market is projected to expand from $10257.72 billion in 2024 to $10822.05 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. The substantial rise during the historical period is due to robust economic progress in developing markets, an increase in the sale of generic drugs, and the growth of advanced healthcare infrastructure.

Anticipated to experience solid growth in the coming years, the market size of pharmaceutical excipients is predicted to increase to “$13948.85 billion by 2029 with a compound annual growth rate (CAGR) of 6.6%. Various factors contributing to the projected growth during this period include government initiatives, the continuous development of innovative drugs, increased spending in healthcare, and a fast-growing elderly population. Trends to observe during this forecast period are the emphasis on sustainable packaging to minimize plastic use, the concentration on mergers and acquisitions in order to fortify market position, efforts on greenhouse gas emission reduction, and the application of artificial intelligence in monitoring nutrient and water levels to enhance supply chain transparency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp

What factors are expected to fuel Pharmaceutical Excipients market growth in the coming years?

The growth of the pharmaceutical excipients market has been fueled by a global rise in the sales of generic drugs. These drugs serve as substitutes for their branded counterparts, maintaining the same dosage, strength, safety, method of administration, and quality. As reported by the India Brand Equity Foundation (IBEF), India reigns as the primary supplier of generic medicines worldwide, with 20% of global generic drug exports originating from the country. In addition, 300 generic drug approvals in the USA were granted to Indian pharmaceutical corporations. The swell in demand for generic drugs is a significant driving force behind the expansion of the pharmaceutical excipients market.

The pharmaceutical excipients market covered in this report is segmented –

1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products

2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities

3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations

Subsegments:

1) By Inorganic Chemicals: Salts, Oxides, Silicates

2) By Organic Chemicals: Sugars, Polymers, Oils And Fats

3) By Other Products: Natural Excipients, Coatings, Antioxidants

Which Emerging Trends And Strategic Shifts Are Shaping The Pharmaceutical Excipients Market?

Leading firms in the pharmaceutical excipient market are pioneering the development of sophisticated excipients like high-purity ones to boost drug formulation’s stability, enhance bioavailability, and accommodate intricate drug delivery systems. High-purity excipients are pharmaceutical excipients refined through advanced purification methods to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical firm based in Switzerland, introduced three new VitiPure excipients, specifically developed to boost the stability and solubility of active pharmaceutical ingredients (APIs). The range includes VitiPure O 80 Superior, a high-purity version of polysorbate 80; VitiPure CO 35 Superior, which is polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer having low bioburden, made for a variety of drug delivery uses, particularly for sensitive substances like mRNA vaccines and biologics are in line with the increasing demand for high-purity components while satisfying rigorous regulatory criteria.

What Are The Most Active Companies In The Pharmaceutical Excipients Market Today?

Major companies operating in the pharmaceutical excipients market include BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Actelion Pharmaceuticals UK Ltd, Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Which Regional Markets Are Attracting The Most Investment In Pharmaceutical Excipients?

North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3415&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model